Combined bioactive approach over atherosclerosis risk BIOMARKERS- Part II

• Grant number: 15/16243-5
• Support Opportunities: Regular Research Grants
• Start date: November 01, 2015
• End date: October 31, 2017
• Field of knowledge: Agronomical Sciences - Food Science and Technology - Food Science
• Principal Investigator: Inar Castro Erger
• Grantee: Inar Castro Erger
• Host Institution: Faculdade de Ciências Farmacêuticas (FCF). Universidade de São Paulo (USP). São Paulo , SP, Brazil

Abstract

Atherosclerosis, one major cause of morbidity and mortality worldwide, is a complex and multifactorial disease triggered especially due to high level of plasma lipids and that involves three mainly conditions: chronic inflammation, dyslipidemia and oxidative stress. Taking into account the high costs of disease management, eminent suboptimal response and low compliance to drug therapies, the combined use of natural bioactive compound able to reduce atherosclerosis risk could provide an additional protection. In this study, the effects of three bioactive components, namely omega-3 fatty acids, plants sterols and polyphenols present in green tea, will be evaluated over atherosclerosis biomarkers in individuals with dyslipidemia and diabetes controlled by drugs. It will be carried out a randomized, placebo-controlled, crossover clinical study, with participation of 70 subjects. At each intervention period, study participants will receive a packaged for the functional or placebo treatment. Functional treatment packaged will be composed by omega 3 softgels (fish oil), a chocolate containing plant sterols and green tea. Placebo treatment will be composed by corn oil softgels, regular chocolate, and anise tea. Subjects will be advised to consume the softgels and chocolate twice a day after main meals and to drink two cups of tea per day. After evaluation of inflammation, dyslipidemia and oxidative stress biomarkers, subjects with the greatest response to the functional treatment will be selected for additional 6 weeks of functional intervention associated to a reduction of the hypolipideamic drugs intake, which will be prescribed individually after evaluation of the responsible physician. (AU)

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

SCOLARO, BIANCA; NOGUEIRA, MARINA S.; PAIVA, ALINE; BERTOLAMI, ADRIANA; BARROSO, LUCIA P.; VAISAR, TOMAS; HEFFRON, SEAN P.; FISHER, EDWARD A.; CASTRO, INAR A.. Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine. MOLECULAR METABOLISM, v. 11, p. 137-144, MAY 2018. (15/16243-5, 14/04247-3, 15/18859-3, 14/18576-9)